COGT Cogent Biosciences, Inc.: institutional ownership and insider trading
335 funds reported holding $8.18B of Cogent Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $268M, with 62 new positions and 44 funds selling out; over the last 12 months insiders bought $0 and sold $384M on the open market.
COGT revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$96.4M, EPS -0.52
- Quarter ended Mar 31, 2026: revenue n/a, net income −$97.4M, EPS -0.53
- Quarter ended Dec 31, 2025: revenue n/a, net income −$102M, EPS -0.61
- Quarter ended Sep 30, 2025: revenue n/a, net income −$80.9M, EPS -0.50
Famous investors holding COGT
- Renaissance Technologies (Renaissance Technologies): $38.6M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $35.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $35.1M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $41.5M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.46M, 0.0% of the portfolio
Largest institutional holders of COGT
- FMR LLC — $994M
- BlackRock, Inc. (BLK) — $672M
- VANGUARD GROUP INC — $409M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $312M
- VANGUARD CAPITAL MANAGEMENT LLC — $287M
- STATE STREET CORP (STT, STT-PG) — $270M
- Jupiter Topco LLC — $256M
- JANUS HENDERSON GROUP PLC (JHG) — $230M
- Fairmount Funds Management LLC — $213M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $194M
Recent COGT insider trades
- Aug 27, 2026: Morris Arlene sold 45,510 shares ($1.69M)
- Mar 31, 2026: Fairmount Funds Management LLC sold 7,000,000 shares ($243M)
- Jan 22, 2026: Fairmount Funds Management LLC sold 3,500,000 shares ($127M)
- Dec 26, 2025: Robinson John Edward sold 90,000 shares ($3.49M)
5%+ owners
- Fairmount Funds Management LLC: 8.6% (Schedule 13D/A, filed Mar 31, 2026)
- BlackRock, Inc.: 8.0% (Schedule 13G/A, filed Jul 27, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Jul 31, 2026)
Who owns the most COGT stock?
The largest institutional holders of Cogent Biosciences, Inc. in the latest 13F filings are FMR LLC ($994M), BlackRock, Inc. (BLK) ($672M), VANGUARD GROUP INC ($409M).
Are insiders buying or selling COGT?
Over the last 12 months insiders bought $0 and sold $384M of Cogent Biosciences, Inc. stock on the open market (SEC Form 4).
Which famous investors own COGT?
Renaissance Technologies, D. E. Shaw, Izzy Englander, Ken Griffin, Two Sigma.
Which ETFs hold COGT?
127 ETFs and mutual funds hold it among their top 100 positions, including IWM, XBI, FCAGX, FOCKX.